Ginkgo bioworks stock prediction.
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business ...
Nov 27, 2023 · Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021. Currently, Ginkgo Bioworks Holdings Inc does not have a price-earnings ratio. Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $315.0 million with a …About Ginkgo Bioworks. Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse ...Cambrium, a leading German start-up focused on the application of generative AI to protein design and synthesis, and Ginkgo Bioworks (NYSE: DNA, "Ginkgo"), which is building the leading platform ...
For Ginkgo Bioworks Holdings Inc Stock (DNA) price forecast for 2024, the average price target for Ginkgo Bioworks Holdings Inc Stock is $4.3465 with a high forecast of $7.2822 and a low forecast of $1.4108. The average DNA price prediction of 2024 represents a +203.95% increase from the last price of $1.43. The current price Ginkgo Bioworks Holdings (DNA) is trading at is $1.43, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Popular ChannelsGinkgo Bioworks Holdings, Inc. (NYSE: DNA, ... million (inclusive of stock-based compensation expense of $111 million), compared to Loss from ... Forward-looking statements are predictions, ...
Jul 5, 2022 · Ark Invest has purchased more than 3.5 million shares of Ginkgo Bioworks since June 29.; The biotech company is now the fund’s 23rd largest holding. Shares of DNA stock are down over 65% year-to ...
About the Ginkgo Bioworks Holdings, Inc. stock forecast. As of 2023 December 01, Friday current price of DNA-WT stock is 0.0898$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Ginkgo Bioworks Holdings stock price has been showing a declining tendency so we believe that similar market …Cathie Wood last bought Ginkgo stock on Aug. 21, but she's been a consistent buyer for quite some time now. Her position is worth around 2.7% of the portfolio, which makes it the 13th-largest holding.Find Salaries by Job Title at Ginkgo BioWorks. 25 Salaries (for 18 job titles) • Updated Oct 29, 2023. How much do Ginkgo BioWorks employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips.DNA stock is rising with a new contract. By William White, InvestorPlace Writer Jul 19, 2023, 9:30 am EST. Ginkgo Bioworks ( DNA) stock is rising alongside a government contract. That contract is ...Get the detailed quarterly/annual income statement for Ginkgo Bioworks Holdings, Inc. (DNA). Find out the revenue, expenses and profit or loss over the last fiscal year.
1. Ginkgo Bioworks. Down by 67% from a year ago, Ginkgo Bioworks ( DNA -7.32%) is a biotech growth stock that has a solid chance of being a favorite pick during the next bull market. While it isn ...
Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More.
Get Ginkgo Bioworks (DNA:NYSE) real-time stock quotes, news, price and financial information from CNBC.Ginkgo Bioworks Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. DNA updated stock price target summary.Ginkgo Bioworks Completes Acquisition of Zymergen ... Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo Class A common stock. Zymergen shares will no longer be traded on Nasdaq. ... These forward-looking statements are only predictions and involve known and unknown …Third quarter 2023 Total revenue of $55 million, down from $66 million in the comparable prior year period, a decrease of 17% primarily driven by the expected ramp down of K-12 testing in Ginkgo's ...Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis.
We expect investors to focus on the sales performance of Ginkgo Bioworks Holdings, Inc.’s DNA two business units when the company reports third-quarter 2023 results on Nov 8 after market close.The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25.DNA Stock Forecast: Welcome to our series of Stock Forecasts, Predictions and Price Targets for 2023, 2024, 2025, 2030.Today we will analyse stocks from both …DNA Stock Forecast: Welcome to our series of Stock Forecasts, Predictions and Price Targets for 2023, 2024, 2025, 2030.Today we will analyse stocks from both technical and fundamental analysis and today’s stock is- DNA, DNA Stock Forecast 2023, 2024, 2025, 2030, 2040, 2050.Ginkgo Bioworks. 11 Aug, 2022, 07:05 ET. SYNB2081 is the second clinical drug candidate developed through the partnership between Ginkgo and Synlogic. CAMBRIDGE, Mass. and BOSTON, Aug. 11, 2022 ...Nov 24, 2023 · Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion. By Chris MacDonald, InvestorPlace Contributor Nov 18, 2022, 1:55 pm EST. Ginkgo Bioworks ( DNA) stock has fallen out of favor in the market. However, Cathie Wood appears to remain very bullish on ...
Cambrium, a leading German start-up focused on the application of generative AI to protein design and synthesis, and Ginkgo Bioworks (NYSE: DNA, "Ginkgo"), which is building the leading platform ...Ginkgo further revised its expectation for Total revenue from $375 – $390 million to $425 –$440 million in 2022. Ginkgo continues to expect Foundry revenue of $165 – $180 million in 2022 ...
The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25.Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis.Ginkgo Bioworks Holdings Inc. analyst ratings, historical stock prices, ... Actuals & Estimates Ginkgo Bioworks Holdings Inc. Quarterly; Annual; Actual Analyst Range Consensus. 0.20 0.00-0.20-0.40.Ginkgo Bioworks Holdings stock price prediction is an act of determining the future value of Ginkgo Bioworks shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Ginkgo Bioworks' future price could yield a significant profit.Forecast Spread, -103 -51,3 -100.02%, -1 606 -64,7 -2381.73%, -593 ... Annual profits - Rate of surprise. Stock · Equities · Stock Ginkgo Bioworks Holdings, Inc.RIJSWIJK, Netherlands and BOSTON, May 25, 2023 /PRNewswire/ -- Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and anti-fungals, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and …Ginkgo Bioworks (DNA 8.53%) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood. Wood's confidence in ...The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25. Ginkgo Bioworks looks cheaper now than it has at pretty much any other time as a public company. That being said, a P/S over 5 with declining revenue and increasing operating losses isn't exactly ...
Ginkgo Bioworks (NYSE: ... Forward-looking statements are predictions, ... There’s still plenty of yield in the stock market even with the recent rally that has resulted in a 19% year-to-date ...
The current price Ginkgo Bioworks Holdings (DNA) is trading at is $1.43, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. …
Mar 2, 2023 · Evgenii Kovalev. Ginkgo Bioworks (NYSE:DNA) is still finding its feet as a public company, with the stock continuing to decline on the back of valuation concerns and declining Biosecurity revenue ... S&P 500 rises on Friday to close at 2023 high: Live updates. Traders work on the floor at the New York Stock Exchange. The S&P 500 soared to a closing high for …Ginkgo Bioworks delivers some encouraging results. In January, Ginkgo released preliminary numbers for the full-year 2022 that indicated strong growth. The company expects its total revenue to ...Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), which is building the leading platform for cell programing and biosecurity, today announced the sale of shares of its Class A common stock ...Aug 18, 2021 · While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections. About Ginkgo Bioworks. Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse ...First quarter 2023 Total revenue of $81 million, down from $168 million in the comparable prior year period, a decrease of 52% driven by the expected ramp down of K-12 testing in Ginkgo's ...S&P 500 rises on Friday to close at 2023 high: Live updates. Traders work on the floor at the New York Stock Exchange. The S&P 500 soared to a closing high for …Ginkgo Bioworks Holdings Inc (DNA) stock is trading at $1.42 as of 9:36 AM on Monday, Dec 4, a loss of -$0.01, or -1.05% from the previous closing price of $1.43. …Mark Massaro’s Buy rating for Ginkgo Bioworks Holdings (DNA) is mainly due to several significant factors. Firstly, DNA has recently announced a new RNA therapeutics deal with Pfizer, which is ...
Dec 1, 2023 · Ginkgo Bioworks Holdings, Inc. has announced that it will host an Investor Day on October 3, 2023. The event will include discussions with the company’s founders and senior management, covering topics related to its cell engineering and biosecurity businesses. DNA Stock Forecasts 2023, 2025 and 2030. Ginkgo Bioworks Stock Forecast 2023: $2.90 Sep 13, 2022 · Let's do a back-of-the-napkin calculation to determine whether this stock has a realistic chance of doubling in value in the next three years. At the moment, Ginkgo's market cap is around $4.5 ... Days after trading under its new ticker after completing its SPAC merger with Soaring Eagle Acquisition, Ginkgo Bioworks (NYSE:DNA) is rising higher today, having …Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results. DNA | March 1, 2023. $478 million of total revenue in 2022, representing an increase of 52% over 2021 and toward the high end of guidance. 59 new Cell Programs added in 2022, representing 90% growth over 2021 and toward the high end of guidance.Instagram:https://instagram. nernxc3 ai stock forecastbest forex trading softwarekbwy dividend Real time Ginkgo Bioworks (DNA) stock price quote, stock graph, news & analysis.BOSTON, Aug. 9, 2023 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results ... steel pennysgenerac stocks Third quarter 2023 Total revenue of $55 million, down from $66 million in the comparable prior year period, a decrease of 17% primarily driven by the expected ramp down of K-12 testing in Ginkgo's ... thimble insurance reviews About Ginkgo Bioworks. Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse ...1 DNA stock price increased by 6.86% over the past day and the current price is below all major EMA’s. 2 Ginkgo Bioworks Holdings Inc. ( NYSE: DNA) stock’s 52-week price range is around $1.12 – $2.55. Ginkgo Bioworks Holdings Inc. reported Q2 revenue is down 44% Y-o-Y, mainly due to a fall in Biosecurity revenue.